Pilot experience of non-invasive delivery of radiofrequency energy in patients with pelvic hypertonia. A novel second-generation technology

Le résumé fourni par la source

Introduction:The pelvic floor dysfunction leading to muscle hypertonia is often idiopathic, but sometimes recognisable disorders may explain the steadily increased pelvic muscle tone in women and men.If tissue temperatures remain below 42°C, radiofrequency technologies induce pain relief and muscle relaxation, probably through neuromodulation, without heat-induced tissue damage.The Dynamic Quadripolar Radiofrequency™ (DQRF™) technology has the further benefit of being non-invasive.The paper reports on the outcomes of the first real-life exploratory study with the DQRF™ technology, combined with radioporation of lenitive and pro-trophic agents (UPR™), in subjects with pelvic floor muscle hypertonia.Methods: Office-based, prospective pilot cohort study in 31 subjects with painful posterior pelvic floor muscle hypertonia, 20 women and 11 men 23 to 60 years old, without discriminating between idiopathic or secondary pelvic floor hypertonia.The DQRF™ device incorporates a novel flat probe ergonomically designed for the radiofrequency treatment of the posterior pelvic floor and anorectal areas.Assessments, at baseline (first treatment session) and end of treatment (last treatment session): carried out according to the validated criteria for pelvic floor dysfunction (IUGA/ICS Joint Report on the Terminology for Female Pelvic Floor Dysfunction); 10-cm VAS for pain; yes/no for evidence of constipation.Results: Normal voluntarily and involuntarily muscle contraction and relaxation at the end of the planned DQRF™ treatment cycle; no loss of benefits over the following weeks and months thanks to the satisfactory compliance to the prescribed at-home exercise and massage program.Pain at the end of the treatment cycle: -83.9% vs baseline.Conclusions: A short cycle of weekly, non-invasive DQRF™ + UPR™ sessions controls pain and the obstructed defecation syndrome effectively in subjects with idiopathic and non-idiopathic pelvic floor muscle hypertonia.The preliminary DQRF™ + UPR™ relaxation of pelvic muscles also facilitates all following physiokinetic therapies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.